ING Groep NV

SEC CIK: 0001039765
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

ABT holding history

Abbott Laboratories in every 13F filed by ING Groep NV, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overview All 13F holders of ABT Full Q2 2026 holdings

Shares (Q2 2026): 1,320,415
Value: $119.8M
% of portfolio: 0.6%
Quarters held: 22; Since Q1 2021

Holdings of ABT by ING Groep NV, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	1,320,415	$119.8M	0.6%	+299,525+29.3%	Added	Holders
Q1 2026	1,020,890	$104.8M	0.6%	+425,449+71.5%	Added	Holders
Q4 2025	595,441	$74.6M	0.4%	+122,063+25.8%	Added	Holders
Q3 2025	473,378	$63.4M	0.3%	+363,503+330.8%	Added	Holders
Q2 2025	109,875	$14.9M	0.1%	−772,863−87.6%	Reduced	Holders
Q1 2025	882,738	$117.1M	0.8%	+529,065+149.6%	Added	Holders
Q4 2024	353,673	$40.0M	0.3%	−99,117−21.9%	Reduced	Holders
Q3 2024	452,790	$51.6M	0.3%	+22,995+5.4%	Added	Holders
Q2 2024	429,795	$44.7M	0.3%	+152,403+54.9%	Added	Holders
Q1 2024	277,392	$31.5M	0.2%	+4,711+1.7%	Added	Holders
Q4 2023	272,681	$30.0M	0.2%	−695,432−71.8%	Reduced	Holders
Q3 2023	968,113	$93.8M	0.8%	−6,586−0.7%	Reduced	Holders
Q2 2023	974,699	$106.3M	0.8%	+592,307+154.9%	Added	Holders
Q1 2023	382,392	$38.7M	0.4%	+369,205+2,799.8%	Added	Holders
Q4 2022	13,187	$1.45M	<0.1%	−159,274−92.4%	Reduced	Holders
Q3 2022	172,461	$16.7M	0.3%	−155,019−47.3%	Reduced	Holders
Q2 2022	327,480	$35.6M	0.4%	−151,777−31.7%	Reduced	Holders
Q1 2022	479,257	$56.7M	0.6%	−98,386−17.0%	Reduced	Holders
Q4 2021	577,643	$81.3M	0.7%	+282,472+95.7%	Added	Holders
Q3 2021	295,171	$34.9M	0.4%	−1,095−0.4%	Reduced	Holders
Q2 2021	296,266	$34.3M	0.5%	+31,321+11.8%	Added	Holders
Q1 2021	264,945	$31.8M	0.7%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.